|View printer-friendly version|
Spring Bank Pharmaceuticals Announces Election of Pamela Klein, M.D., to its Board of Directors
“We are thrilled to welcome Dr. Klein to our Board of Directors,” said
Dr. Klein noted, “I am delighted to join the Board of Directors of
Dr. Klein is a principal and founder of PMK BioResearch, which offers strategic consulting in oncology drug development to corporate boards, management teams and the investment community. She previously served as Chief Medical Officer of Intellikine, which was acquired by
Source: Spring Bank Pharmaceuticals, Inc.